These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9274850)

  • 1. Blood monitoring of bezafibrate in a chronic hemodialysis patient.
    Takeda K; Nakamoto M; Yasunaga C; Nishihara G; Matsuo K; Urabe M; Goya T
    Nephron; 1997; 76(4):487-8. PubMed ID: 9274850
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of bezafibrate concentration by high performance liquid-chromatography in serum of rats treated with lead nitrate.
    Anchisi C; Fadda AM; Maccioni AM; Dessì S
    Farmaco; 1998; 53(10-11):690-2. PubMed ID: 10205855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of plasma lipid levels in patients undergoing long-term hemodialysis--with special reference to the effects of antilipemic drugs and fatty acid emulsion].
    Tsuchiya M; Kawamura J
    Nihon Jinzo Gakkai Shi; 1975 Apr; 17(4):195-207. PubMed ID: 1239595
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute rhabdomyolysis and hemoglobin reduction after bezafibrate overdose in hyperlipidemic patients on hemodialysis.
    Bedani PL; Perini L; Gilli P
    Nephron; 1994; 68(4):512-3. PubMed ID: 7870241
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of hyperlipidaemia by bezafibrate treatment in RDT patients.
    Grützmacher P; Scheuermann E; Lang W
    Proc Eur Dial Transplant Assoc; 1981; 18():169-75. PubMed ID: 7036147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the nicotinic acid analogue niceritrol on lipoprotein Lp(a) and coagulation-fibrinolysis status in patients with chronic renal failure on hemodialysis.
    Shoji T; Nishizawa Y; Kawasaki K; Tabata T; Matsushita Y; Inoue T; Morii H
    Nephron; 1997; 77(1):112-3. PubMed ID: 9380227
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD.
    Yang KC; Fang CC; Su TC; Lee YT
    Am J Kidney Dis; 2005 Mar; 45(3):e57-60. PubMed ID: 15754265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of bioavailable peroxisome proliferator-activated receptor gamma modulators by a cell-based luciferase reporter system.
    del Bas JM; Laos S; Caimari A; Crescenti A; Arola L
    Anal Biochem; 2012 Aug; 427(2):187-9. PubMed ID: 22613053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia and anemia induced by niceritrol used for amelioration of hyperphosphatemia in a hemodialysis patient.
    Wakasugi H; Futami T; Muso E; Ono T; Sasayama S; Inui K
    Nephron; 2000 Sep; 86(1):97-8. PubMed ID: 10971163
    [No Abstract]   [Full Text] [Related]  

  • 11. [Case of secondary carnitine deficiency (in a patient undergoing hemodialysis), developing rhabdomyolysis due to dehydration and the action of a hypolipemic agent].
    Kawashima N; Shindo R; Fusegawa H; Sato F
    Nihon Naika Gakkai Zasshi; 1993 Dec; 82(12):2066-7. PubMed ID: 8294807
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet aggregation before and after hemodialysis in chronic renal insufficiency.
    Kageyama T; Oyabu H; Tsumoto S; Kimoto S; Toda H
    Bull Osaka Med Sch; 1983 Oct; 29(2):62-8. PubMed ID: 6680327
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood 17-hydroxycorticosteroids and their elimination during hemodialysis in acute and chronic renal insufficiency].
    Timokhov VS; Ryzhenko VM; Shaposhnikova VV
    Ter Arkh; 1976; 48(10):99-104. PubMed ID: 1024286
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood serum ferritin level in patients with chronic renal failure treated by repeated hemodialysis].
    Kowalski D; Starzyk J
    Wiad Lek; 1988 Oct; 41(19):1274-8. PubMed ID: 3247742
    [No Abstract]   [Full Text] [Related]  

  • 15. [Disorders of blood coagulation and fibrinolysis in patients with chronic renal failure during treatment with hemodialysis, and methods of correction].
    Neĭmark MI
    Ter Arkh; 1984; 56(7):48-53. PubMed ID: 6484834
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of long-term hemodialysis on changes in the concentration of various trace elements in the blood of patients with chronic renal failure].
    Weyde W; Adamiec R
    Pol Tyg Lek; 1983 Jan; 38(2):45-9. PubMed ID: 6856497
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of hemodialysis on the blood coagulation system].
    Stetsiuk EA; Lopatkin NA; Mikheeva LA; Iarmolinskiĭ IS; Chudnovskaia MV
    Urol Nefrol (Mosk); 1988; (4):46-51. PubMed ID: 3218018
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of long-term hemodialysis on the blood insulin level in patients with chronic renal failure].
    Pachelski J; Kokot F; Grzeszczak W
    Pol Arch Med Wewn; 1988 May; 79(5):263-70. PubMed ID: 3078196
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of highly water-soluble fibrate derivatives via BGLation.
    Nemoto H; Kamiya M; Nakamoto A; Matsushita T; Matsumura K; Hattori H; Kawamura T; Taoka C; Abe S; Ishizawa K; Miyamoto L; Tsuchiya K
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6425-8. PubMed ID: 22975299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemostatic changes during hemodialysis of patients with chronic kidney insufficiency].
    Randelović S; Krstić C; Susa S; Dumović B; Malesević M; Pantović R; Butorajac J; Durutović R; Lazić D; Ninković D
    Vojnosanit Pregl; 1982; 39(5):344-8. PubMed ID: 7164346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.